Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
danshen + glucose
- Development stage
- Unknown
- Lead developer
- Harbin Yuheng Pharmaceutical
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
Danshen + Glucose (also known as Danshen-glucose injection) is a traditional Chinese medicine (TCM) injectable formulation consisting of an extract of *Salvia miltiorrhiza* (Danshen) dissolved in a glucose solution carrier. Danshen is the primary active herbal ingredient, recognized for its cardiovascular pharmacological properties, including anti-myocardial ischemia, anti-inflammatory, and antithrombotic effects. The drug is administered intravenously and is indicated for the treatment of cardiovascular conditions such as coronary artery disease, angina pectoris, and myocardial infarction. It works by improving microcirculation, inhibiting platelet aggregation, and protecting the myocardium from ischemic damage. Harbin Gloria Pharmaceuticals has conducted Phase 1 clinical safety studies (e.g., CTR20130943) to evaluate the tolerability and safe dose range of this formulation in healthy adult volunteers.
- Brand names
- Shenxiong glucose injection
- Other names
- Danshen-glucose injectionSalvia miltiorrhiza extract in glucose
Beyond the preview
Go deeper on danshen + glucose.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on danshen + glucose.